You are about to leave the Clinical Value website now.

Cancel
unnamed 2 1

Diagnostic challenges in primary hepatocellular carcinoma: case reports and review of the literature

HCC diagnosis can be particularly challenging in some cases and the obtained results seem ambiguous, resulting in a long-term and delayed diagnostic process.This paper presents three case reports where the diagnosis could not be made promptly and the patients died as a result of a delayed diagnostic process. Pazgan-Simon M, Serafinska S, Janocha-Litwin J, Simon K, Zuwala-Jagiello J

Read more

Recent Articles

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Load more articles

You May Also Like

discussing treatment options with colleague 1
Consensus
17 March 2023

Utility of Combining PIVKA-II and AFP in the Surveillance and Monitoring of Hepatocellular Carcinoma in the Asia-Pacific Region

A panel of 17 experts from Asia-Pacific, gathered to discuss and reach a consensus on the clinical usefulness and value of PIVKA-II for the surveillance and treatment monitoring of HCC,…

Read More
Biomarkers
17 March 2023

A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma

This review highlights promising candidate biomarkers and biomarker panels that have completed phase II evaluation for the early detection of HCC. Parikh ND, Mehta AS, Singal AG, Block T, Marrero…

Read More
Expert Opinions
13 February 2024

The Pursuit for Better Patient Outcomes – Innovating HCC Management at Siriraj Hospital

Read More

Be the first to receive updates, event opportunities, and thought leadership insights.

The information contained in this website is intended for healthcare professionals only.
Click “OK” if you are a healthcare professional.

OK